After starting an experimental drug called zatolmilast, Jason Mazzola experienced significant improvements in focus, confidence, and independence, reshaping his everyday life.
His mother, Lizzie Mazzola, noted, 'I have a different child in my house,' reflecting a monumental change in Jason's ability to self-manage and participate in daily activities.
In a 2021 study involving adult males with Fragile X, zatolmilast usage led to enhancements in memory and language skills, supporting anecdotal reports of its benefits.
With two larger studies in progress, zatolmilast might become the first FDA-approved treatment specifically for Fragile X syndrome, providing hope to affected families.
Collection
[
|
...
]